Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Ganciclovir Sodium Injection, Bedford ANDA 76-222 GANCICLOVIR Capsule; 250MG GANCICLOVIR Ranbaxy | 076457 GANCICLOVIR Capsule; 500MG GANCICLOVIR Ranbaxy | 020460 GANCICLOVIR Capsule; 250MG CYTOVENE ROCHE PALO | 020460 GANCICLOVIR Capsule; 500MG CYTOVENE ROCHE PALO | 020569 GANCICLOVIR Implant; Implantation 4.5MG VITRASERT BAUSCH AND LOMB | 076222 GANCICLOVIR SODIUM Injection 500MG BASE/VIAL GANCICLOVIR SODIUM Bedford | 019661 GANCICLOVIR SODIUM Injection 500MG BASE/VIAL CYTOVENE IV ROCHE PALO | Cytovene (Ganciclovir) Injection, Hoffmann-La Roche, Labeling Revision | Zirgan (ganciclovir) Ophthalmic Gel, Sirion Therapeutics, Inc., Approval ^ FDA's latest approval appears at the bottom of this list. ^                                                                                      A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2009 Betterchem.com